Predicting Antigen‐Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist

Approaches to analyze and cluster T-cell receptor (TCR) repertoires to reflect antigen specificity are critical for the diagnosis and prognosis of immune-related diseases and the development of personalized therapies. Sequence-based approaches showed success but remain restrictive, especially when the amount of experimental data used for the training is scarce. Structure-based approaches which represent powerful alternatives, notably to optimize TCRs affinity toward specific epitopes, show limitations for large-scale predictions. To handle these challenges, TCRpcDist is presented, a 3D-based approach that calculates similarities between TCRs using a metric related to the physico-chemical properties of the loop residues predicted to interact with the epitope. By exploiting private and public datasets and comparing TCRpcDist with competing approaches, it is demonstrated that TCRpcDist can accurately identify groups of TCRs that are likely to bind the same epitopes. Importantly, the ability of TCRpcDist is experimentally validated to determine antigen specificities (neoantigens and tumor-associated antigens) of orphan tumor-infiltrating lymphocytes (TILs) in cancer patients. TCRpcDist is thus a promising approach to support TCR repertoire analysis and TCR deorphanization for individualized treatments including cancer immunotherapies.

Authors

Institutions

Publication Details

Journal
Advanced Science
Published
2024-08-19
DOI
https://doi.org/10.1002/advs.202405949
Citations
6
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
1.70

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Predicting Antigen‐Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist

Maiia E. Bragina, George Coukos, Christophe Sauvage, Marion Arnaud et al.
6 citations
Advanced Science
CAR-T cell therapy research
1.70
article

Predicting Antigen‐Specificities of Orphan T Cell Receptors from Cancer Patients with TCRpcDist

Maiia E. Bragina, George Coukos, Christophe Sauvage, Marion Arnaud, Johanna Chiffelle, Alexandre Harari, Vincent Zoete, Sara Bobisse, Denarda Dangaj Laniti, Michal Bassani‐Sternberg, David Barras, Florian Huber, Marine Bugnon, Francesca Mayol‐Rullan, Marta A. S. Perez
article en
6 citations

Abstract

Approaches to analyze and cluster T-cell receptor (TCR) repertoires to reflect antigen specificity are critical for the diagnosis and prognosis of immune-related diseases and the development of personalized therapies. Sequence-based approaches showed success but remain restrictive, especially when the amount of experimental data used for the training is scarce. Structure-based approaches which represent powerful alternatives, notably to optimize TCRs affinity toward specific epitopes, show limitations for large-scale predictions. To handle these challenges, TCRpcDist is presented, a 3D-based approach that calculates similarities between TCRs using a metric related to the physico-chemical properties of the loop residues predicted to interact with the epitope. By exploiting private and public datasets and comparing TCRpcDist with competing approaches, it is demonstrated that TCRpcDist can accurately identify groups of TCRs that are likely to bind the same epitopes. Importantly, the ability of TCRpcDist is experimentally validated to determine antigen specificities (neoantigens and tumor-associated antigens) of orphan tumor-infiltrating lymphocytes (TILs) in cancer patients. TCRpcDist is thus a promising approach to support TCR repertoire analysis and TCR deorphanization for individualized treatments including cancer immunotherapies.

Advanced ScienceVol. 11(40)
SIB Swiss Institute of Bioinformatics (CH), Ludwig Cancer Research (CH), University of Lausanne (CH)
National Science Foundation, Ludwig Institute for Cancer Research, Biltema Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Université de Lausanne, Fondation ISREC
Openalex Percentile: Top 13%
CAR-T cell therapy research
1.70
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.